Efficacy of Biomarkers and CEUS Versus CTA in AAA Follow-up Post-EVAR
Recruiting
Observational Study
Abdominal Aortic Aneurysm Without Rupture
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Instituto de Investigacion Sanitaria La Fe · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective observational study evaluates the efficacy of contrast-enhanced ultrasound and biomarker determination in the follow-up of patients with abdominal aortic aneurysm (AAA) treated with Endovascular Aneurysm Repair (EVAR). Currently, computed tomography angiography (CTA) is the standard for follow-up, although it has disadvantages such as radiation exposure and the use of iodinated co…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with AAA under follow-up who are going to be treated with EVAR.
* signed informed consent to perform CTA, CEUS and for the determination of biomarkers.
Exclusion Criteria:
* patients with inflammatory abdominal aortic aneurysms or ruptured aneurysm.
Contacts